[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dianthus Therapeutics Inc (DNTH)

Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dianthus Therapeutics Inc 7 Times Square 43rd Floor New York NY 10036 USA

www.dianthustx.com Employees: 92 P: 929-999-4055

Sector:

Medical

Description:

Dianthus Therapeutics Inc. is a privately-held, clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics. Dianthus Therapeutics Inc., formerly known as Magenta Therapeutics Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 4,672,303
Enterprise Value, $K 4,621,213
Shares Outstanding, K 54,666
Float, K 53,015
% Float 96.98%
Short Interest, K 6,565
Short Float 12.01%
Days to Cover 8.33
Short Volume Ratio 0.52
% of Insider Shareholders 3.02%
% of Institutional Shareholders 47.53%

Financials:

Annual Sales, $ 2,040 K
Annual Net Income, $ -162,340 K
Last Quarter Sales, $ 280 K
Last Quarter Net Income, $ -64,430 K
EBIT, $ -177,940 K
EBITDA, $ -183,680 K

Growth:

1-Year Return 320.51%
3-Year Return 753.71%
5-Year Return -51.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 84.65%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.85 on 05/05/26
Next Earnings Date 08/06/26
Earnings Per Share ttm -4.10
EPS Growth vs. Prev Qtr 40.56%
EPS Growth vs. Prev Year -3.66%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-16 on 09/12/23

DNTH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -38.79%
Return-on-Assets % -36.32%
Profit Margin % -7,957.84%
Debt/Equity 0.00
Price/Sales 2,427.75
Price/Cash Flow N/A
Price/Book 7.92
Book Value/Share 11.42
Interest Coverage -3.73
60-Month Beta 1.18
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.